The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 05, 2016
Filed:
Dec. 19, 2014
Applicant:
Toray Industries, Inc., Tokyo, JP;
Inventors:
Naoki Izumimoto, Kamakura, JP;
Hidenori Mochizuki, Kamakura, JP;
Assignee:
Toray Industries, Inc., , JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61K 31/197 (2006.01); A61K 31/415 (2006.01); A61K 45/06 (2006.01); A61K 31/421 (2006.01); A61K 31/426 (2006.01); A61K 31/195 (2006.01); A61K 31/422 (2006.01); A61K 31/427 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4439 (2013.01); A61K 31/195 (2013.01); A61K 31/197 (2013.01); A61K 31/415 (2013.01); A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/426 (2013.01); A61K 31/427 (2013.01); A61K 45/06 (2013.01);
Abstract
A method treats or prevents neuropathic pain with a synergistically-enhanced analgesic effect at a dose at which a calcium channel α2δ ligand does not produce any side effects as well as which agent does not produce any new side effects on the central nervous system. The therapeutic agent or a prophylactic agent used in the method includes as effective ingredients a cyclohexane derivative or a pharmaceutically acceptable salt thereof or a prodrug thereof, and a calcium channel α2δ ligand.